COVID-19 vaccine-related axillary edema in breast imaging setting.

Radiol Case Rep

University of Toronto, Joint Department of Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, 610 University Avenue - M5G 2M9, Toronto, Ontario, Canada.

Published: March 2022

Worldwide, many vaccines have been developed in response to the COVID-19 pandemic. Unilateral reactive axillary adenopathy related to the COVID-19 vaccine is a well-known occurrence. In addition, axillary edema has also been observed following COVID-19 vaccinations in patients undergoing breast MRI, and radiologists need to be aware of this possibility to avoid performing unnecessary work-up that can be costly to the health care system and be stressful for patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712278PMC
http://dx.doi.org/10.1016/j.radcr.2021.11.075DOI Listing

Publication Analysis

Top Keywords

axillary edema
8
covid-19
4
covid-19 vaccine-related
4
vaccine-related axillary
4
edema breast
4
breast imaging
4
imaging setting
4
setting worldwide
4
worldwide vaccines
4
vaccines developed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!